U.S. Markets closed

Opexa Therapeutics, Inc. (OPXA)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.9699-0.1001 (-9.3551%)
At close: 3:59PM EDT
People also watch
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue2,905.1652,556.3291,271.895
Cost of Revenue---
Gross Profit2,905.1652,556.3291,271.895
Operating Expenses
Research Development6,497.53110,039.49612,118.629
Selling General and Administrative3,122.3374,258.1473,833.37
Non Recurring1,036.4671,036.4671,036.467
Total Operating Expenses10,894.462--
Operating Income or Loss-7,991.617-12,093.884-15,067.883
Income from Continuing Operations
Total Other Income/Expenses Net9.18373.43915.62
Earnings Before Interest and Taxes-7,982.434-12,020.445-15,052.263
Interest Expense---
Income Before Tax-7,982.434-12,020.445-15,052.263
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-7,982.434-12,020.445-15,052.263
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-7,980.114-12,019.278-15,052.263
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-7,980.114-12,019.278-15,052.263